课题基金 / 基金详情

The mechanisms by which circulating macrophages and their liver counterparts (Kupffer and hepatic stellate cells) alter CD8+ T-cell activity

The mechanisms by which circulating macrophages and their liver counterparts (Kupffer and hepatic stellate cells) alter CD8+ T-cell activity
循环巨噬细胞及其肝脏对应物(枯否细胞和肝星状细胞)改变 CD8 T 细胞活性的机制
批准号:
RGPIN-2015-05674
负责人:
Crawley, Angela
金额:
$2.55万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31

项目摘要

项目成果

Crawley, Angela的其他基金

相似基金

相关文献

中文摘要
翻译
背景: 巨噬细胞等先天免疫细胞协调T细胞的反应是适应性免疫的一个标志。巨噬细胞亚群的细胞因子的产生和细胞与细胞的接触对CD4+T细胞亚群分化的影响已经得到了很好的描述,但它们对CD8+T细胞活性和细胞溶解(CTL)功能的控制尚不清楚。血源性巨噬细胞最近被描述为M1、M2a、2b和2c亚群,建立炎症、免疫调节或组织修复细胞因子环境。此外,组织特异性巨噬细胞在维持免疫耐受、平衡CD8+T细胞渗入的免疫反应和组织破坏效应方面的作用仍有待充分描述。例如,在非酒精性脂肪性肝病中,肝脏驻留巨噬细胞(Kupffer细胞,KC和肝星状细胞,HSC)最近被描述极化为M1和M2样表型,但它们对M2a,2b或2c亚群分化的可能性尚未被研究。M1和M2亚群固有的促炎和抗炎特性可能增强或抑制CD8+T细胞活性和CTL功能。 假设:单核细胞来源的M1和M2亚群,以及同等来源的肝脏巨噬细胞亚群(库普弗细胞和肝星状细胞),分别增强或抑制CD8+T细胞的活性。 具体目标: 目的#1:确定M1、M2a、M2b和M2c亚群对CD8+T细胞活性的间接和直接影响。 目的#2:确定肝巨噬细胞(Kupffer细胞)能否分化为M1、M2a、2b和2c样亚群,并探讨其对CD8+T细胞活性的影响。 目的#3:研究人星状细胞分化为巨噬细胞亚群并介导CD8+T细胞活性的可能性。 相关性: 这项研究将解决巨噬细胞亚群如何影响CD8+T细胞活性的根本问题。增加的一个新的组成部分是根据巨噬细胞表型和它们在适应性免疫T细胞反应中的作用来表征Kupffer细胞和肝星状细胞亚群。将先天免疫系统和获得性免疫系统与这些方法联系起来,将确定目前尚不清楚的巨噬细胞亚群和CD8+T细胞在耐受和免疫反应中的关系,特别是在肝脏中。
英文摘要
BACKGROUND: The orchestration of T-cell responses by innate immune cells such as macrophages is a hallmark of adaptive immunity. The effect of cytokine production and cell-cell contact of macrophage subsets has been well described for CD4+ T-cell subset differentiation, while their control of CD8+ T-cell activity and cytolytic (CTL) function remains unclear. Blood-derived macrophages have been recently described to polarize into M1, M2a, 2b and 2c subsets, establishing inflammatory, immunoregulatory or tissue-repairing cytokine milieus. In addition, the role of tissue-specific macrophages in maintaining immune tolerance and balancing the immune response and tissue destructive effects of infiltrating CD8+ T-cells remains to be fully described. For example, liver resident macrophages (Kupffer cells, KC, and hepatic stellate cells, HSC) have recently been described to polarize to M1- and M2-like phenotypes in non-alcoholic fatty liver disease, yet their potential for M2a, 2b or 2c subset differentiation has not been investigated. The inherent pro- and anti-inflammatory attributes of M1 and M2 subsets may enhance or inhibit CD8+ T-cell activity and CTL function. Hypothesis: Blood monocyte-derived M1 and M2 subsets, and equivalently derived subsets of liver resident macrophages (Kupffer cells and hepatic stellate cells), enhance or inhibit CD8+ T-cell activity, respectively. SPECIFIC AIMS: AIM #1: Identify the indirect and direct effects of M1, M2a, M2b and M2c subsets on CD8+ T-cell activity. AIM #2: Determine if liver macrophages (Kupffer cells) can be polarized into M1, M2a, 2b and 2c-like subsets and investigate their influence on CD8+ T-cell activity. AIM #3: Investigate the potential of human stellate cells to be polarized into macrophage subsets and to mediate CD8+ T-cell activity. RELEVANCE: This study will address the fundamental issue of how macrophage subsets influence CD8+ T-cell activity. An added novel component is the characterization of Kupffer cell and hepatic stellate cell subsets according to macrophage phenotypes and their role in adaptive immunity T-cell responses. Linking the innate and adaptive immune systems with these approaches will identify the as yet poorly understood relationship between macrophage subsets and CD8+ T-cells in tolerance and immune response, specifically in the liver.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The mechanisms by which circulating macrophages and their liver counterparts (Kupffer and hepatic stellate cells) alter CD8+ T-cell activity
  • 批准号:
    RGPIN-2015-05674
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $5.1万
  • 财政年份:
    2021
  • 负责人:
    Crawley, Angela
  • 依托单位:
The mechanisms by which circulating macrophages and their liver counterparts (Kupffer and hepatic stellate cells) alter CD8+ T-cell activity
  • 批准号:
    RGPIN-2015-05674
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.55万
  • 财政年份:
    2019
  • 负责人:
    Crawley, Angela
  • 依托单位:
The mechanisms by which circulating macrophages and their liver counterparts (Kupffer and hepatic stellate cells) alter CD8+ T-cell activity
  • 批准号:
    RGPIN-2015-05674
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.55万
  • 财政年份:
    2018
  • 负责人:
    Crawley, Angela
  • 依托单位:
The mechanisms by which circulating macrophages and their liver counterparts (Kupffer and hepatic stellate cells) alter CD8+ T-cell activity
  • 批准号:
    RGPIN-2015-05674
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.55万
  • 财政年份:
    2017
  • 负责人:
    Crawley, Angela
  • 依托单位:
国内基金
海外基金
基于量子点多色荧光细胞标志谱型的CTC鉴别与肿瘤个体化诊治的研究
  • 批准号:
    30772507
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2007
  • 负责人:
    赵晓航
  • 依托单位: